CIK 0001661998
- Non-accelerated filer
- Smaller reporting company
Q32 Bio Inc.
Sign in to watch- Ticker
- QTTB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473468154
- Phone
- +1 781-999-0232
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Former names
- Q32 Bio Inc., Homology Medicines, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,875,000 shares at $8.00 ($15,000,000)
- 4 Open-market buy Director bought 1,875,000 shares at $8.00 ($15,000,000)
- 4 Grant or award Chief Scientific Officer acquired 37,500 shares (grant or award)
- 4 Grant or award CEO acquired 132,000 shares (grant or award)
- 4 Grant or award CFO and President acquired 53,250 shares (grant or award)
- 4 Open-market sale CFO and President sold 3,995 shares at $4.51 ($18,035)
- 4 Open-market sale CEO sold 9,896 shares at $4.51 ($44,675)
- 4 Open-market sale Chief Scientific Officer sold 2,815 shares at $4.51 ($12,708)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CEO sold 22,506 shares at $3.46 ($77,871)
- 4 Open-market sale CFO and President sold 9,072 shares at $3.46 ($31,395)
Page 2 of 15 · 295 filings